Could 5′-N and S ProTide analogues work as prodrugs of antiviral agents?

0519335 - ÚOCHB 2021 RIV GB eng J - Článek v odborném periodiku
Procházková, Eliška - Hřebabecký, Hubert - Dejmek, Milan - Šála, Michal - Šmídková, Markéta - Tloušťová, Eva - Zborníková, Eva - Eyer, Luděk - Růžek, Daniel - Nencka, Radim
Could 5′-N and S ProTide analogues work as prodrugs of antiviral agents?
Bioorganic and Medicinal Chemistry Letters. Roč. 30, č. 4 (2020), č. článku 126897. ISSN 0960-894X. E-ISSN 1464-3405
Grant CEP: GA MZd(CZ) NV16-34238A; GA MŠMT(CZ) EF16_019/0000729; GA MŠMT LO1302
Institucionální podpora: RVO:61388963 ; RVO:60077344
Klíčová slova: antiviral * nucleotide * prodrug * ProTide * HCV * 31P NMR spectroscopy
Obor OECD: Organic chemistry; Microbiology (BC-A)
Impakt faktor: 2.823, rok: 2020
Způsob publikování: Omezený přístup
https://www.sciencedirect.com/science/article/pii/S0960894X19308753?via%3Dihub

The nucleoside/nucleotide derived antiviral agents have been the most important components of antiviral therapy used in clinics. Recently, the focus of the medicinal chemists within this exciting research field has been affected mainly by the lack of effective therapies for the Hepatitis C virus (HCV) infection and several other “neglected” diseases caused by viruses such as Zika or Dengue. 2′-Methyl modified nucleosides and their monophosphate prodrugs (ProTides) have revolutionized the therapies for HCV in the last few years and, according to the latest research efforts, have also brought a promise for treatment of diseases caused by other members of Flaviviridae family. Here, we report on the design and synthesis of 5’-N and S modified ProTides derived from 2′-methyladenosine. We studied potential applicability of these derivatives as prodrugs of this archetypal antiviral compound.
Trvalý link: http://hdl.handle.net/11104/0304523